A detailed history of Heartland Advisors Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Heartland Advisors Inc holds 81,748 shares of BDX stock, worth $18.3 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
81,748
Previous 65,680 24.46%
Holding current value
$18.3 Million
Previous $15.4 Million 28.4%
% of portfolio
1.05%
Previous 0.88%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$221.47 - $242.41 $3.56 Million - $3.9 Million
16,068 Added 24.46%
81,748 $19.7 Million
Q2 2024

Aug 08, 2024

BUY
$225.07 - $246.17 $10.8 Million - $11.8 Million
48,075 Added 273.08%
65,680 $15.4 Million
Q1 2024

May 07, 2024

BUY
$233.45 - $247.73 $695,914 - $738,483
2,981 Added 20.38%
17,605 $4.36 Million
Q4 2023

Feb 08, 2024

BUY
$232.24 - $267.23 $57,595 - $66,273
248 Added 1.73%
14,624 $3.57 Million
Q3 2023

Nov 08, 2023

SELL
$254.9 - $283.59 $41,293 - $45,941
-162 Reduced 1.11%
14,376 $3.72 Million
Q2 2023

Aug 10, 2023

BUY
$238.39 - $265.32 $7,151 - $7,959
30 Added 0.21%
14,538 $3.84 Million
Q1 2023

May 11, 2023

BUY
$229.71 - $259.35 $70,750 - $79,879
308 Added 2.17%
14,508 $3.59 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $857,443 - $1.01 Million
-3,928 Reduced 21.67%
14,200 $3.61 Million
Q3 2022

Nov 10, 2022

BUY
$51.03 - $264.23 $117,522 - $608,521
2,303 Added 14.55%
18,128 $4.04 Million
Q2 2022

Aug 12, 2022

BUY
$234.74 - $275.42 $1.9 Million - $2.23 Million
8,111 Added 105.15%
15,825 $3.9 Million
Q1 2022

May 12, 2022

BUY
$243.64 - $270.48 $1.88 Million - $2.09 Million
7,714 New
7,714 $2.05 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Heartland Advisors Inc Portfolio

Follow Heartland Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Advisors Inc with notifications on news.